VORAXAZE

Swiss trademark · 639622 · Combined mark · In force

Register entry

Registration number
639622
Application number
62735/2012
Status
In force
Type
Combined mark
As registered
VORAXAZE ((fig.))
Filed
Oct 25, 2012
Registered
Feb 8, 2013
Published
Feb 8, 2013
Protected until
Oct 25, 2032
Priority
14.05.2012 US
Vienna classes
27.05.01, 27.05.04
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, die Methotrexat-Gegenmittel enthalten; pharmazeutische Präparate zur Verwendung in der Chemotherapie und bei Autoimmunerkrankungen; pharmazeutische Präparate zur Verwendung in der Regulierung der Toxizität von Therapeutika; pharmazeutische Präparate zum Abbau von Therapeutika-Konzentrationen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 5, 2023

    Holder’s address changed

    Owner
    Protherics Medicines Development Limited, 5 Fleet Place, London, EC4M 7RD, United Kingdom → Protherics Medicines Development Limited, C/O Collyer Bristow LLP, 140 Brompton Road, Knightsbridge, London SW3 1HY, United Kingdom

    Published in Swissreg on 05.07.2023

  2. Aug 24, 2022

    Agent removed

    Representative
    A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich (removed)

    Published in Swissreg on 24.08.2022

  3. Aug 8, 2022

    Renewed

    Published in Swissreg on 08.08.2022

  4. Apr 16, 2014

    Agent’s address changed

    Representative
    A. W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  5. Feb 8, 2013

    Registered

    Published in Swissreg on 08.02.2013

Parties

Holder

Protherics Medicines Development Limited

C/O Collyer Bristow LLP 140 Brompton Road Knightsbridge, London SW3 1HY, GB

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.